E-Learning

Advent Eyes New Mid-Market Strategy for Smaller Deals

(Bloomberg) -- Buyout firm Advent is contemplating setting up an investment vehicle targeting mid-sized transactions as it looks to bolster its core private equity business.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionAdvent, which is focused on buying controlling stakes in businesses, raised $25 billion for its flagship buyout fund in 2022 — its largest fundraising to date. The firm sees a “fi

Read more

Why Is Purple Biotech Stock Trading Higher On Monday?

On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody that blocks CEACAM1, in patients with pancreatic ductal adenocarcinoma (PDAC). Purple Biotech stock is trading higher with a strong session volume of 9.7 million, compared to an average volume of 48.73K as per data from Benzinga Pro. The Phase 2 study evaluated CM24 in combination with Bristol Myers Squibb & Co’s (NYSE:BMY) immu

Read more

How To Earn $500 A Month From Marvell Technology Stock Ahead Of Q3 Earnings

Marvell Technology, Inc. (NASDAQ:MRVL) will release earnings results for the third quarter, after the closing bell, on Tuesday, Dec. 3. Analysts expect the Wilmington, Delaware-based company to report quarterly earnings at 41 cents per share. Marvell projects to report quarterly revenue of $1.46 billion. That’s more than the $1.42 billion it reported a year earlier, according to data from Benzinga Pro. On Nov. 27, Susquehanna analyst Christopher Rolland maintained Marvell Tech with a Positive ra

Read more